The Impact of Tissue Sialylation on Macrophage Polarization and Function

组织唾液酸化对巨噬细胞极化和功能的影响

基本信息

  • 批准号:
    10188417
  • 负责人:
  • 金额:
    $ 63.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-10 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Summary Tissue-resident macrophages play important roles in maintain tissue homeostasis. They broadly fall into two categories: classically-activated and pro-inflammatory macrophages (M1) and alternatively-activated and anti- inflammatory macrophages (M2). Within immune privileged tissues, such as the lung and liver, macrophages, such as liver Kupffer cells, are typically described as M2. Our preliminary data suggests that the M2 phenotype in the liver depends at least in part upon the glycome of the surrounding parenchyma, particularly the hepatocytes. We have found that α2,6-linked sialic acids upon hepatocyte surface glycans promotes normal M2 polarization, but that loss of this sialylation drives M1 polarization and subsequent aberrant T cell activation which leads to increased inflammatory disease susceptibility. In this proposal, we seek to determine the mechanism by which α2,6-sialylated glycans in the liver drives changes in resident macrophage phenotype and T cell activation. The proposed studies are broken into three aims, with the first two focused upon the influence of α2,6-sialylated glycans on macrophage function and signaling, and the third focused upon the mechanism underlying increased T cell activation and disease in the absence of sialylation. We believe that these studies will introduce a novel immune checkpoint receptor which binds sialylated glycans, inhibits signal transduction, promotes M2 polarization, and leads to immune homeostasis.
摘要 组织驻留巨噬细胞在维持组织动态平衡方面发挥着重要作用。它们大致分为两类 分类:经典激活和促炎巨噬细胞(M1)和交替激活和抗炎巨噬细胞 炎性巨噬细胞(M2)。在免疫特权组织内,如肺和肝脏,巨噬细胞, 如肝脏枯否细胞,通常被描述为M2。我们的初步数据表明,M2表型 在肝脏中,至少部分地取决于周围实质的糖类,特别是 肝细胞。我们发现肝细胞表面糖链上的α-2,6-联结唾液酸促进正常M2 极化,但这种唾液酸化缺失会导致M1极化和随后的异常T细胞激活 这会增加炎症性疾病的易感性。在这项建议中,我们寻求确定 肝脏中α2,6-唾液酸化多聚糖驱动驻留巨噬细胞表型改变和 T细胞活化。拟议的研究分为三个目标,前两个重点是影响 α的2,6-唾液酸聚糖对巨噬细胞功能和信号转导的影响;第三种侧重于其机制 在没有唾液酸化的情况下,潜在的T细胞活化和疾病。我们相信这些研究 将引入一种新的免疫检查点受体,它结合唾液酸聚糖,抑制信号转导, 促进M2分化,导致免疫动态平衡。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian A Cobb其他文献

Brian A Cobb的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian A Cobb', 18)}}的其他基金

The Impact of Tissue Sialylation on Macrophage Polarization and Function
组织唾液酸化对巨噬细胞极化和功能的影响
  • 批准号:
    10406978
  • 财政年份:
    2020
  • 资助金额:
    $ 63.8万
  • 项目类别:
The Impact of Tissue Sialylation on Macrophage Polarization and Function
组织唾液酸化对巨噬细胞极化和功能的影响
  • 批准号:
    10621916
  • 财政年份:
    2020
  • 资助金额:
    $ 63.8万
  • 项目类别:
Regulatory Mechanisms of Glycoprotein Sialylation
糖蛋白唾液酸化的调控机制
  • 批准号:
    10152265
  • 财政年份:
    2016
  • 资助金额:
    $ 63.8万
  • 项目类别:
Regulatory Mechanisms of Glycoprotein Sialylation
糖蛋白唾液酸化的调控机制
  • 批准号:
    10798844
  • 财政年份:
    2016
  • 资助金额:
    $ 63.8万
  • 项目类别:
Regulatory Mechanisms of Glycoprotein Sialylation
糖蛋白唾液酸化的调控机制
  • 批准号:
    10321684
  • 财政年份:
    2016
  • 资助金额:
    $ 63.8万
  • 项目类别:
Regulatory Mechanisms of Glycoprotein Sialylation
糖蛋白唾液酸化的调控机制
  • 批准号:
    10529336
  • 财政年份:
    2016
  • 资助金额:
    $ 63.8万
  • 项目类别:
Immunology Training Program-Predoctoral
免疫学培训项目-博士前
  • 批准号:
    10269569
  • 财政年份:
    2010
  • 资助金额:
    $ 63.8万
  • 项目类别:
Immunology Training Program-Predoctoral
免疫学培训项目-博士前
  • 批准号:
    10646422
  • 财政年份:
    2010
  • 资助金额:
    $ 63.8万
  • 项目类别:
Immunology Training Program - Predoctoral
免疫学培训计划 - 博士前
  • 批准号:
    8431999
  • 财政年份:
    2010
  • 资助金额:
    $ 63.8万
  • 项目类别:
Immunology Training Program - Predoctoral
免疫学培训计划 - 博士前
  • 批准号:
    8617791
  • 财政年份:
    2010
  • 资助金额:
    $ 63.8万
  • 项目类别:

相似海外基金

Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
  • 批准号:
    10836880
  • 财政年份:
    2023
  • 资助金额:
    $ 63.8万
  • 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
  • 批准号:
    10734324
  • 财政年份:
    2023
  • 资助金额:
    $ 63.8万
  • 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
  • 批准号:
    10740465
  • 财政年份:
    2023
  • 资助金额:
    $ 63.8万
  • 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
  • 批准号:
    23K04971
  • 财政年份:
    2023
  • 资助金额:
    $ 63.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
  • 批准号:
    2885451
  • 财政年份:
    2023
  • 资助金额:
    $ 63.8万
  • 项目类别:
    Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
  • 批准号:
    10385926
  • 财政年份:
    2022
  • 资助金额:
    $ 63.8万
  • 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
  • 批准号:
    10509043
  • 财政年份:
    2022
  • 资助金额:
    $ 63.8万
  • 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
  • 批准号:
    10704008
  • 财政年份:
    2022
  • 资助金额:
    $ 63.8万
  • 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
  • 批准号:
    10818273
  • 财政年份:
    2022
  • 资助金额:
    $ 63.8万
  • 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
  • 批准号:
    10349397
  • 财政年份:
    2022
  • 资助金额:
    $ 63.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了